Biofrontera (BFRI) Non Operating Income (2020 - 2025)

Biofrontera's Non Operating Income history runs 6 years deep, the most recent figure standing at -$208000.0 for Q4 2025.

• On a quarterly basis, Non Operating Income fell 166.45% year-over-year to -$208000.0 in Q4 2025; TTM through Dec 2025 was -$540000.0, a 117.8% decrease from a year earlier, with the FY2025 full-year figure at -$452000.0, up 14.23% from the prior year.
• Non Operating Income slipped to -$208000.0 in Q4 2025 per BFRI's latest filing, from -$111000.0 in the prior quarter.
• Across five years, Non Operating Income topped out at $8.7 million in Q1 2022 and bottomed at -$12.6 million in Q4 2021.
• The 5-year median for Non Operating Income is -$108500.0 (2025), against an average of $227600.0.
• Across the five-year window, Non Operating Income soared 174120.0% in 2022 and tumbled 397.18% in 2024, its largest moves.
• Year by year, Non Operating Income stood at -$12.6 million in 2021, then surged by 122.47% to $2.8 million in 2022, then tumbled by 107.48% to -$212000.0 in 2023, then jumped by 247.64% to $313000.0 in 2024, then sank by 166.45% to -$208000.0 in 2025.
• Per Business Quant, the three latest BFRI Non Operating Income figures stand at -$208000.0 (Q4 2025), -$111000.0 (Q3 2025), and -$115000.0 (Q2 2025).